Literature DB >> 1247556

Nitrobenzylthionionosine binding sites in the erythrocyte membrane.

C E Cass, A R Paterson.   

Abstract

Nitrobenzylthioinosine binds tightly, but reversibly, to sites in the human erythrocyte membrane; occupancy of these sites blocks the transport of uridine and of other nucleosides. This report described the inhibition of nitrobenzylthioinosine binding at these sites by substrates of the uridine transport mechanism and by compounds related to nitrobenzylthioinosine. For some of these compounds dissociation constants for binding at the nitrobenzylthioinosine sites were determined, assumming competition with nitrobenzylthioinosine. Deoxycytidine, a substrate for the uridine transport mechanism, did not inhibit binding of nitrobenzylthioinosine, suggesting that binding sites for the latter are distinct from nucleoside sites directly involved in transport.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247556     DOI: 10.1016/0005-2736(76)90354-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

Review 1.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

2.  Nucleoside transport in mammalian cell membranes. IV. Organomercurials and organomercurial-mercaptonucleoside complexes as probes for nucleoside transport systems in hamster cells.

Authors:  O Bibi; J Schwartz; Y Eilam; E Shohami; Z I Cabantchik
Journal:  J Membr Biol       Date:  1978-03-10       Impact factor: 1.843

3.  S-(N-dansylaminoethyl)-6-mercaptoguanosine as a fluorescent probe for the uridine transport system in human erythrocytes.

Authors:  E Shohami; R Koren
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

4.  Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).

Authors:  M F Vickers; R S Mani; M Sundaram; D L Hogue; J D Young; S A Baldwin; C E Cass
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

5.  Nucleoside transport in human and sheep erythrocytes. Evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites.

Authors:  S M Jarvis; J D Young
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

6.  Nucleoside transport in human erythrocytes. Apparent molecular weight of the nitrobenzylthioinosine-binding complex estimated by radiation-inactivation analysis.

Authors:  S M Jarvis; J D Young; J C Ellory
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

7.  Proteolytic cleavage of [3H]nitrobenzylthioinosine-labelled nucleoside transporter in human erythrocytes.

Authors:  N S Janmohamed; J D Young; S M Jarvis
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

8.  Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites.

Authors:  S M Jarvis; D McBride; J D Young
Journal:  J Physiol       Date:  1982-03       Impact factor: 5.182

9.  Kinetics of nitrobenzylthioinosine binding to the human erythrocyte nucleoside transporter.

Authors:  S M Jarvis; S N Janmohamed; J D Young
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

10.  Binding of nitrobenzylthioinosine to high-affinity sites on the nucleoside-transport mechanism of HeLa cells.

Authors:  E Dahlig-Harley; Y Eilam; A R Paterson; C E Cass
Journal:  Biochem J       Date:  1981-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.